Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,288,800
-$378,975 QoQ
Shares Held
30,049
-21.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CreativeOne Wealth, LLC holds $5,576,451 across 11 Biotechnology names. EXEL ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
29,421 | $1,901,479 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
30,049 | $1,288,800 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,924 | $859,142 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
659 | $509,169 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
10,750 | $291,217 | |
| 6 | INSM |
INSMED Inc
|
1,485 | $242,827 | |
| 7 | MGTX |
MeiraGTx Holdings plc
|
26,424 | $228,831 | |
| 8 | ARDX |
Ardelyx, Inc.
|
22,793 | $136,530 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,288,800 | 30,049 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,667,775 | 38,051 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,325,812 | 32,102 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $599,796 | 13,607 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $294,510 | 7,977 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $399,600 | 12,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $203,370 | 7,837 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||